SenzaGen AB (SENZA.ST)

SEK 7.0

(0.0%)

Net Income Summary of SenzaGen AB

SenzaGen AB's latest annual net income in 2023 was -22.09 Million SEK , up 11.3% from previous year.
SenzaGen AB's latest quarterly net income in 2024 Q1 was -3.06 Million SEK , up 68.75% from previous quarter.
SenzaGen AB reported an annual net income of -24.91 Million SEK in 2022, up 20.53% from previous year.
SenzaGen AB reported an annual net income of -31.34 Million SEK in 2021, down -14.76% from previous year.
SenzaGen AB reported a quarterly net income of -3.06 Million SEK for 2024 Q1, up 68.75% from previous quarter.
SenzaGen AB reported a quarterly net income of -9.79 Million SEK for 2023 Q4, down -100.0% from previous quarter.

Annual Net Income Chart of SenzaGen AB (2023 - 2014)

Historical Annual Net Income of SenzaGen AB (2023 - 2014)

Year	Net Income	Net Income Growth
2023	-22.09 Million SEK	11.3%
2022	-24.91 Million SEK	20.53%
2021	-31.34 Million SEK	-14.76%
2020	-27.31 Million SEK	45.63%
2019	-50.23 Million SEK	-212.22%
2018	-16.09 Million SEK	-23.83%
2017	-12.99 Million SEK	-45.31%
2016	-8.94 Million SEK	-212.99%
2015	-2.85 Million SEK	-1190.46%
2014	262 Thousand SEK	0.0%

Year	Net Income	Net Income Growth
2024 Q2	-7.74 Million SEK	-153.09%
2024 Q1	-3.06 Million SEK	68.75%
2023 Q4	-9.79 Million SEK	-100.0%
2023 Q2	-12.3 Million SEK	-150.67%
2023 FY	-22.09 Million SEK	11.3%
2023 Q1	-4.9 Million SEK	57.01%
2023 Q3	-4.89 Million SEK	60.2%
2022 Q2	-13.49 Million SEK	-100.0%
2022 Q4	-11.41 Million SEK	-100.0%
2022 FY	-24.91 Million SEK	20.53%
2022 Q1	-6.74 Million SEK	61.32%
2022 Q3	-5.7 Million SEK	57.7%
2021 Q2	-13.9 Million SEK	-100.0%
2021 FY	-31.34 Million SEK	-14.76%
2021 Q4	-17.44 Million SEK	-100.0%
2021 Q3	-8.72 Million SEK	37.24%
2021 Q1	-6.95 Million SEK	51.33%
2020 Q1	-6.44 Million SEK	81.61%
2020 FY	-27.31 Million SEK	45.63%
2020 Q4	-14.28 Million SEK	-100.0%
2020 Q3	-7.14 Million SEK	44.6%
2020 Q2	-12.88 Million SEK	-100.0%
2019 Q3	-17.52 Million SEK	-15.29%
2019 Q2	-15.19 Million SEK	-100.0%
2019 Q1	-7.59 Million SEK	-99.3%
2019 FY	-50.23 Million SEK	-212.22%
2019 Q4	-35.04 Million SEK	-100.0%
2018 FY	-16.09 Million SEK	-23.83%
2018 Q1	-4.23 Million SEK	-75.62%
2018 Q2	-4.23 Million SEK	0.0%
2018 Q3	-3.81 Million SEK	9.92%
2018 Q4	-3.81 Million SEK	0.0%
2017 Q2	-4.08 Million SEK	0.0%
2017 FY	-12.99 Million SEK	-45.31%
2017 Q3	-2.41 Million SEK	41.03%
2017 Q1	-4.08 Million SEK	-122.54%
2017 Q4	-2.41 Million SEK	0.0%
2016 FY	-8.94 Million SEK	-212.99%
2016 Q3	-1.83 Million SEK	29.72%
2016 Q2	-2.61 Million SEK	0.0%
2016 Q1	-2.61 Million SEK	0.0%
2016 Q4	-1.83 Million SEK	0.0%
2015 FY	-2.85 Million SEK	-1190.46%
2014 FY	262 Thousand SEK	0.0%

Peer Net Income Comparison of SenzaGen AB

Name	Net Income	Net Income Difference
AroCell AB (publ)	-59.29 Million SEK	62.735%
Devyser Diagnostics AB (publ)	-53.6 Million SEK	58.774%
Immunovia AB (publ)	-309.43 Million SEK	92.859%
Prostatype Genomics AB (publ)	-41.43 Million SEK	46.671%
Spermosens AB	-12.2 Million SEK	-81.093%